Literature DB >> 16415909

Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5-hydroxytryptamine depletion in the brain.

Snezana Kusljic1, Jan Brosda, Maarten van den Buuse.   

Abstract

Evidence is increasing for a role of brain 5-hydroxytryptamine (5-HT) systems in schizophrenia. We previously showed that brain 5-HT depletion causes disruption of prepulse inhibition, a measure of sensorimotor gating that is deficient in schizophrenia. Antipsychotic treatment has been reported to reverse these deficits in patients with schizophrenia. The present study was designed to investigate the ability of antipsychotic drugs to reverse prepulse inhibition deficits caused by lesions of the brain 5-HT system in rats. In male Sprague-Dawley rats, selected parts of the brain 5-HT systems were lesioned by micro-injection of the 5-HT neurotoxin 5,7-dihydroxytryptamine into the dorsal raphe nucleus (DRN) or median raphe nucleus (MRN). The effects of antipsychotic drugs on lesion-induced changes in prepulse inhibition were examined 2 weeks after the surgery. There was significant disruption of prepulse inhibition in the MRN-lesioned group compared to sham-operated controls. This deficiency in prepulse inhibition was restored by clozapine (1 and 5 mg kg(-1)) treatment, and by treatment with a relatively high dose of haloperidol (0.25 mg kg(-1)). There was no significant effect of the DRN lesions on prepulse inhibition compared with sham-operated controls. These results indicate that 5-HT depletion in MRN-innervated brain structures leads to disruption of prepulse inhibition. Treatment with both antipsychotic drugs, haloperidol and clozapine, significantly increased prepulse inhibition in these animals back to the level seen in sham-operated controls. The present findings highlight the importance of the 5-HT systems in cognitive models of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415909      PMCID: PMC1751510          DOI: 10.1038/sj.bjp.0706641

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

Review 1.  The dopamine hypothesis of reward: past and current status.

Authors:  R Spanagel; F Weiss
Journal:  Trends Neurosci       Date:  1999-11       Impact factor: 13.837

Review 2.  Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Authors:  S Kapur; P Seeman
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 3.  Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

Authors:  M J Millan
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

4.  Can animal models help to understand human diseases? Commentary on Swerdlow et al., 'Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon'.

Authors:  M Koch
Journal:  Behav Pharmacol       Date:  2000-06       Impact factor: 2.293

Review 5.  Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia.

Authors:  B Dean
Journal:  Aust N Z J Psychiatry       Date:  2000-08       Impact factor: 5.744

Review 6.  The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

Authors:  R A Bantick; J F Deakin; P M Grasby
Journal:  J Psychopharmacol       Date:  2001-03       Impact factor: 4.153

7.  A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo.

Authors:  H L Rowley; P L Needham; I C Kilpatrick; D J Heal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-02       Impact factor: 3.000

Review 8.  Cognitive deficit in schizophrenia and its neurochemical basis.

Authors:  A Breier
Journal:  Br J Psychiatry Suppl       Date:  1999

9.  Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone.

Authors:  R S Mansbach; J Carver; S H Zorn
Journal:  Pharmacol Biochem Behav       Date:  2001 Jul-Aug       Impact factor: 3.533

10.  Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.

Authors:  P J Fletcher; Z F Selhi; A Azampanah; T L Sills
Journal:  Neuropsychopharmacology       Date:  2001-04       Impact factor: 7.853

View more
  4 in total

Review 1.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

2.  Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats.

Authors:  Marco Bortolato; Roberto Frau; Marco Orrù; Maria Collu; Giampaolo Mereu; Manolo Carta; Fabio Fadda; Roberto Stancampiano
Journal:  Psychopharmacology (Berl)       Date:  2008-03-12       Impact factor: 4.530

3.  Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.

Authors:  Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

4.  Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats.

Authors:  Jana Lotter; Marisa Möller; Olivia Dean; Michael Berk; Brian H Harvey
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.